In addition, studies have demonstrated that USP20 triggers the activation of multiple pathways, including Wnt, MAPK, HIF1, NF-κB, cell cycle checkpoint and many other signaling pathways [33, 57–60], promoting the processes of multiple cancer types (Fig. 3). The gene discussed is USP20; the disease is cancer.